Chemotherapy for metastatic transitional carcinoma of the urinary tract: A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure

A study of cyclophosphamide, adriamycin,

A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract

✍ Dennis L. Citrin; Tom F. Hogan; Tom E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 2 views

Twenty patients with locally advanced and/or metastatic transitional cell cancer of the urinary tract were treated with cyclophosphamide 500 mg/m2, Adriamycin (doxorubicin) 40 mg/m2 and cis-platinum (CDDP) 40 mg/m2 given every three weeks for 2 cycles, alternating with methotrexate 40 mg/m2 weekly f